Core Viewpoint - Jiangtian Chemical (300927) reported that as of October 20, 2025, the number of shareholders in its consolidated ordinary accounts and margin trading credit accounts is 13,228 [1] Summary by Category - **Company Information** - Jiangtian Chemical has a total of 13,228 shareholders in its combined ordinary and margin trading credit accounts as of the specified date [1]

Core Insights - Jiangtian Chemical (300927.SZ) reported significant revenue growth for the first three quarters of 2025, achieving 1.109 billion yuan, a year-on-year increase of 112.58% [1] - However, the net profit attributable to shareholders decreased by 75.84% to 8.2111 million yuan, and the net profit after excluding non-recurring gains and losses fell by 82.02% to 5.8108 million yuan [1] - The company generated a net cash flow from operating activities of 108 million yuan, marking a substantial increase of 485.32% [1] Financial Performance Summary - For Q3 2025, Jiangtian Chemical's revenue reached 357 million yuan, up 110.37% year-on-year [1] - The net profit attributable to shareholders for Q3 2025 was 7.9534 million yuan, a decline of 10.49% compared to the previous year [1] - The net profit after excluding non-recurring gains and losses for Q3 2025 was 7.9355 million yuan, reflecting a growth of 2.79% [1] Previous Year Comparison - In 2024, Jiangtian Chemical reported revenue of 688 million yuan, a decrease of 2.92% year-on-year [1] - The net profit attributable to shareholders in 2024 was 298 million yuan, an increase of 334.35% [1] - The net profit after excluding non-recurring gains and losses for 2024 was 40.0871 million yuan, down 39.48% [1] - The net cash flow from operating activities in 2024 was 16.3287 million yuan, a decline of 81.27% [1] Company Background - Jiangtian Chemical was listed on the Shenzhen Stock Exchange's Growth Enterprise Market on January 7, 2021, with an initial public offering of 20.05 million shares at a price of 13.39 yuan per share [2] - The total funds raised from the IPO amounted to approximately 268.47 million yuan, with a net amount of about 228.48 million yuan after deducting issuance costs [2] - The company planned to use the raised funds for various projects, including the production of specific chemical products and the establishment of a green intelligent factory [2]

Core Viewpoint - Jiangtian Chemical announced the election of its fifth board of directors, consisting of 9 members, with 6 non-independent directors and 3 independent directors [2] Group 1: Board Composition - The fifth board of directors will include 6 non-independent directors and 3 independent directors [2] - One of the non-independent directors is an employee representative elected by the employee representative assembly, which does not require shareholder meeting approval [2] Group 2: Director Nominations - The board's nomination committee has approved the nomination of 8 candidates for the fifth board, including 5 non-independent directors and 3 independent directors [2] - The nominated independent director, Yu Dong, is a professional accountant [2]

Core Insights - Jiangtian Chemical reported a significant increase in revenue for Q3 2025, achieving 356,582,306.91 yuan, which represents a year-on-year growth of 110.37% [2] - However, the net profit attributable to shareholders decreased to 7,953,397.96 yuan, reflecting a year-on-year decline of 10.49% [2] Financial Performance - Revenue for Q3 2025: 356.58 million yuan, up 110.37% year-on-year [2] - Net profit for Q3 2025: 7.95 million yuan, down 10.49% year-on-year [2]

Core Viewpoint - Jiangtian Chemical (300927.SZ) reported significant revenue growth in the third quarter, but net profit experienced a substantial decline [1] Financial Performance - The company achieved a revenue of 1.109 billion yuan in the first three quarters, representing a year-on-year increase of 112.58% [1] - The net profit attributable to shareholders was 8.21 million yuan, reflecting a year-on-year decrease of 75.84% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 5.81 million yuan, down 82.02% year-on-year [1]

Group 1 - The core point of the article highlights Jiangtian Chemical's significant revenue growth in Q3 2025, with a year-on-year increase of 112.58%, reaching approximately 1.109 billion yuan [1] - The net profit attributable to shareholders decreased by 75.84%, amounting to around 8.21 million yuan [1] - Basic earnings per share also saw a decline of 75.83%, reported at 0.0569 yuan [1] Group 2 - As of the report, Jiangtian Chemical's market capitalization stands at 3.8 billion yuan [1]

证券代码：300927 证券简称：江天化学 公告编号：2025-046 声明人吴建新作为南通江天化学股份有限公司第5届董事会 独立董事候选人，已充分了解并同意由提名人南通江天化学股份有 限公司董事会提名为南通江天化学股份有限公司(以下简称该公司) 第5届董事会独立董事候选人。现公开声明和保证，本人与该 公司之间不存在任何影响本人独立性的关系，且符合相关法 律、行政法规、部门规章、规范性文件和深圳证券交易所业 务规则对独立董事候选人任职资格及独立性的要求，具体声 明并承诺如下事项： 一、本人已经通过南通江天化学股份有限公司第4届董事会提 名委员会或者独立董事专门会议资格审查，提名人与本人不 存在利害关系或者其他可能影响独立履职情形的密切关系。 ☑ 是 □否 如否，请详细说明：______________________________ 二 、本人不存在《中华人民共和国公司法》第一百四十 六条等规定不得担任公司董事的情形。 ☑ 是 否 如否，请详细说明：______________________________ 三 、本人符合中国证监会《上市公司独立董事管理办法》 和深圳证券交易所业务规则规定的独立董事任职资格 ...

南通江天化学股份有限公司 关于董事会换届选举的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 证券代码：300927 证券简称：江天化学 公告编号：2025-044 南通江天化学股份有限公司（以下简称"公司"或"本公司"）第四届董事 会任期即将届满，根据《公司法》《深圳证券交易所创业板股票上市规则》《深 圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》等法 律法规、规范性文件及《公司章程》的有关规定，公司按照相关法律程序进行了 董事会换届选举。 公司于 2025 年 10 月 21 日召开了第四届董事会第十八次会议，审议通过了 《关于公司董事会换届选举暨提名第五届董事会非独立董事候选人的议案》《关 于公司董事会换届选举暨提名第五届董事会独立董事候选人的议案》。 公司第五届董事会由 9 名董事组成，其中非独立董事 6 名（其中 1 名职工董 事由职工代表大会选举产生，无需提交股东会审议），独立董事 3 名。经公司董 事会提名委员会资格审核，董事会同意提名朱辉先生、陈云光先生、陈东明先生、 陈弘颖女士、薛菁华女士为公司第五届董事会非独立 ...

证券代码：300927 证券简称：江天化学 公告编号：2025-048 声明人宋义虎作为南通江天化学股份有限公司第5届董事会 独立董事候选人，已充分了解并同意由提名人南通江天化学股份有 限公司董事会提名为南通江天化学股份有限公司(以下简称该公司) 第5届董事会独立董事候选人。现公开声明和保证，本人与该 公司之间不存在任何影响本人独立性的关系，且符合相关法 律、行政法规、部门规章、规范性文件和深圳证券交易所业 务规则对独立董事候选人任职资格及独立性的要求，具体声 明并承诺如下事项： 一、本人已经通过南通江天化学股份有限公司第4届董事会提 名委员会或者独立董事专门会议资格审查，提名人与本人不 存在利害关系或者其他可能影响独立履职情形的密切关系。 ☑ 是 □否 如否，请详细说明：______________________________ 二 、本人不存在《中华人民共和国公司法》第一百四十 六条等规定不得担任公司董事的情形。 ☑ 是 否 如否，请详细说明：______________________________ 三 、本人符合中国证监会《上市公司独立董事管理办法》 和深圳证券交易所业务规则规定的独立董事任职资格 ...

证券代码：300927 证券简称：江天化学 公告编号：2025-049 如否，请详细说明：______________________________ 三 、被提名人符合中国证监会《上市公司独立董事管理 办法》和深圳证券交易所业务规则规定的独立董事任职资格 和条件。 ☑ 是 □否 提名人南通江天化学股份有限公司董事会现就提名郁东为南通 江天化学股份有限公司第 5 届董事会独立董事候选人发表公开声 明。被提名人已书面同意作为南通江天化学股份有限公司第 5 届 董事会独立董事候选人(参见该独立董事候选人声明)。本次提名是 在充分了解被提名人职业、学历、职称、详细的工作经历、全 部兼职、有无重大失信等不良记录等情况后作出的，本提名人 认为被提名人符合相关法律、行政法规、部门规章、规范性文件 和深圳证券交易所业务规则对独立董事候选人任职资格及独立 性的要求，具体声明并承诺如下事项： 一、被提名人已经通过南通江天化学股份有限公司第 4 届董 事会提名委员会或者独立董事专门会议资格审查，提名人与被 提名人不存在利害关系或者其他可能影响独立履职情形的密切 关系。 ☑ 是 □否 如否，请详细说明：______________ ...